Core Viewpoint - Jura Energy Corporation has announced the sale of its entire 60% working interest in the Sara & Suri Block to Oil and Gas Development Company Limited (OGDCL), along with the transfer of operatorship, as part of a strategic move to streamline its asset portfolio and reduce costs [1][2][3]. Group 1: Sale Transaction Details - The sale transaction involves Spud Energy (Pty) Limited, a wholly owned subsidiary of Jura, transferring its 60% working interest and operatorship of the Sara & Suri Block to OGDCL, effective April 30, 2025, subject to regulatory approval [1][7]. - OGDCL will pay a gross consideration of US$105,000 to Spud and will assume all obligations related to the Sara & Suri Block, including abandonment and reclamation obligations [7]. - The anticipated reduction in monthly operating costs for Spud is approximately US$12,000 [8]. Group 2: Rationale Behind the Sale - The decision to sell is influenced by the shut-in production from the Sara & Suri Block since July 2023 due to a significant drop in pressure and flow rates, leading to potential abandonment and reclamation obligations of approximately US$1.5 million [2][8]. - Jura aims to unlock shareholder value through this divestment while also pursuing enforcement of arbitration awards against Petroleum Exploration (Pvt.) Limited (PEL) [3][4]. Group 3: Arbitration Proceedings - Jura is involved in two arbitration proceedings against PEL regarding the Badin IV North and South blocks, with the first arbitration resolved in favor of Jura in December 2024 [4]. - The second arbitration is ongoing and is being pursued through the International Chamber of Commerce [4]. Group 4: Regulatory and Closing Conditions - The sale of the Sara & Suri Block is subject to regulatory approval in Pakistan and customary closing conditions, with an expected closing date near the end of Q4 2025 [5].

Core Viewpoint - Niu Technologies reported strong sales growth in the second quarter of 2025, with a total of 350,090 units sold, reflecting a significant increase compared to the previous year, driven by a focus on product development and market expansion [2][3]. Sales Performance - In the second quarter of 2025, NIU sold 350,090 units, a 36.7% increase from 256,162 units in the same period of 2024 [2]. - Sales in the China market reached 318,719 units, up from 207,552 units in 2Q 2024, while international sales were 31,371 units, down from 48,610 units [2]. - For the first half of 2025, total sales were 553,403 units, compared to 385,301 units in the first half of 2024, indicating a 43.7% year-over-year growth [2]. Product Strategy - The company focused on enhancing its key product lines, resulting in an optimized product mix that appeals to a broader consumer base [3]. - During the "618 Shopping Festival," NIU's high-end models achieved top rankings on major e-commerce platforms, reinforcing its position in China's premium market [3]. International Expansion - NIU launched a comprehensive portfolio of electric motorcycles, including off-road models, supported by an expanded distribution network, which has strengthened its global market position despite challenges in the micromobility sector [4]. Company Overview - NIU is recognized as a leading provider of smart urban mobility solutions, offering a diversified product portfolio that includes electric motorcycles, mopeds, bicycles, kick-scooters, and e-bikes [6]. - The company employs an omnichannel retail model, integrating both offline and online sales channels to enhance customer service [6].

Company Overview - Spectral Medical Inc. is a late-stage theranostic company focused on advancing therapeutic options for sepsis and septic shock [1][5] - The company is seeking U.S. FDA approval for its product Toraymyxin™ (PMX), a therapeutic hemoperfusion device that removes endotoxin from the bloodstream [5][6] Financial Activities - Spectral has filed a preliminary short form base shelf prospectus to qualify the distribution of up to $100 million in various securities over a 25-month period [2][3] - The specific terms of any offering will be established in a prospectus supplement filed with the applicable Securities Regulators [2] Clinical Development - PMX is already approved for therapeutic use in Japan and Europe, with over 360,000 uses to date [6] - The Tigris Trial is a confirmatory study of PMX, designed as a 2:1 randomized trial involving 150 patients [7] Market Context - Approximately 330,000 patients are diagnosed with septic shock in North America each year, indicating a significant market opportunity for the company's products [6]

Core Viewpoint - Banco Comercial Português, SA has released an interim report detailing the transactions conducted under its Share Buy-Back Programme, indicating a strategic move to enhance shareholder value through repurchasing shares [1] Group 1: Share Buy-Back Programme - The report outlines the total number of shares repurchased under the programme, reflecting the company's commitment to returning capital to shareholders [1] - The interim report provides insights into the financial implications of the buy-back transactions, including the impact on earnings per share and overall market perception [1] - The company emphasizes the importance of the buy-back programme in maintaining a strong capital structure and supporting stock price stability [1]

Core Viewpoint - Banco Itaú Chile has launched its first Sustainable Finance Framework, aimed at issuing green, social, and sustainability-linked instruments in alignment with international standards [1][2]. Group 1: Sustainable Finance Framework - The Framework is designed to support Chile's energy transition and social inclusion agenda, emphasizing sustainability as a core aspect of the bank's financing strategy [1]. - S&P Global Ratings provided a Second Party Opinion, rating the Framework's alignment with global standards as "Strong" [1]. Group 2: Commitment to Sustainability - Itaú Chile's initiative reflects a strong commitment to sustainability, integrated into its business strategy through actions like sustainable finance and carbon footprint measurement [2]. - The bank aims to contribute to a resilient, inclusive, and low-emission economy, reinforcing the belief that finance can drive sustainable development [2].

Core Insights - Subsea 7 S.A. has been awarded a sizeable contract offshore Egypt for the engineering, procurement, commissioning, and installation of flexible pipelines, umbilicals, and associated subsea components [1][2] - The project management and engineering work will commence immediately at Subsea 7's offices in France, Portugal, and Egypt, with offshore activities expected to start in 2026 [1][2] - Subsea 7 defines a sizeable contract as being between $50 million and $150 million [2] Company Overview - Subsea 7 is recognized as a global leader in delivering offshore projects and services for the energy industry, focusing on creating sustainable value and being the partner of choice in the sector [3]

Core Points - The article discusses the total number of shares and voting rights of Orange, in compliance with French commercial regulations [1] - A double voting right is granted to fully paid-up shares held in registered form for at least two years, effective from April 3, 2016 [1] Summary by Category Share Information - As of January 31, 2025, Orange has a total of 2,660,056,599 shares, with 3,835,000 treasury shares without voting rights, resulting in 3,172,669,760 theoretical voting rights and 3,169,834,760 exercisable voting rights [2] - By June 30, 2025, the total number of shares remains the same at 2,660,056,599, with treasury shares decreasing to 1,456,848, leading to 3,180,452,886 theoretical voting rights and 3,178,996,038 exercisable voting rights [2] Voting Rights - The number of theoretical voting rights fluctuates slightly over the months, starting from 3,172,669,760 in January 2025 and reaching 3,180,452,886 by June 2025 [2] - The number of exercisable voting rights also shows a similar trend, starting at 3,169,834,760 in January and increasing to 3,178,996,038 by June [2]

Regulated information Half-year report on Atos SE’s liquidity contract Paris, France - July 4, 2025 Pursuant to the liquidity contract entered into by Atos SE with Rothschild Martin Maurel, as at June 30, 2025, the following assets appeared on the liquidity account: 10,500 Atos shares € 1,291,866.00 Over the period from January 1, 2025, to June 30,2025, negotiations totalled: Number of transactionsNumber of shares tradedAmount of transactions in €Purchase4,63130,243,85713,932,498.88Sale4,737<td style="wi ...

INVITATION TO THE MEDIA & ANALYST WEBCAST July 25, 2025, 11:00 a.m. Half year results 2025 and outlook Steinhausen, July 4, 2025 – We cordially invite you to the media, analyst and investor conference of Schweiter Technologies. In addition to information on the 2025 half year results, we are pleased to give you an outlook for the second half year. The webcast will take place on July 25, 2025 at 11:00 a.m. CEST and can be accessed with this link: https://www.webcast-eqs.com/schweiter-2025-h1. Roman Sondere ...

Core Points - The liquidity contract between Nexity and Rothschild Martin Maurel was reported as of 30 June 2025, detailing the assets in the liquidity account [2] - Nexity is listed on the SRD and Compartment B of Euronext and is a member of several indices including SBF80, SBF120, CAC Mid60, CAC Mid & Small, and CAC All Tradable [2] Summary of Transactions - In the first half of 2025, Nexity purchased 1,791,937 shares for a total of €19,454,576 across 7,073 transactions and sold 1,776,937 shares for €19,265,379 across 10,413 transactions [4] - As of 31 December 2024, the liquidity account had 0 shares and €3,629,606 [4] - In the second half of 2024, Nexity purchased 1,984,940 shares for €23,767,085 and sold 2,154,940 shares for €25,533,260 [4] - On 2 May 2024, when the liquidity contract with Rothschild Martin Maurel was implemented, the liquidity account had 273,110 shares and €577,349 [4]